Death or Neurodevelopmental Impairment at 18 To 22 Months in a Randomized Trial of Early Dexamethasone to Prevent Death or Chronic Lung Disease in Extremely Low Birth Weight Infants

OBJECTIVE: To evaluate the incidence of death or neurodevelopmental impairment (NDI) at 18 to 22 months corrected age in subjects enrolled in a trial of early dexamethasone treatment to prevent death or chronic lung disease in extremely low birth weight infants. METHODS: Evaluation of infants at 18...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Stark, Ann R., Carlo, Waldemar A., Vohr, Betty R, Papile, Lu Ann, Saha, Shampa, Bauer, Charles R., Donovan, Edward F., Oh, William, Shankaran, Seetha, Tyson, Jon E., Wright, Linda L., Poole, W. Kenneth, Das, Abhik, Stoll, Barbara J., Fanaroff, Avroy A., Korones, Sheldon B., Ehrenkranz, Richard A., Stevenson, David K., Peralta-Carcelen, Myriam, Adams-Chapman, Ira, Wilson-Costello, Deanne E., Bada, Henrietta S., Heyne, Roy J., Johnson, Yvette R., Lee, Kimberly Gronsman, Steichen, Jean J., Hintz, Susan R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4120744/
https://ncbi.nlm.nih.gov/pubmed/23992673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpeds.2013.07.027
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados